Make your money go further for just 25p per day

PREMIUM
AIM IHT

Fevertree Drinks: is the valuation justified?

Fever-Tree Blood orange

Shares in the premium mixer group rose strongly as it reported in-line results and, more significantly, reiterated guidance for the current year. With new product launches coming thick and fast and a greatly expanded distribution in the key US market, the future looks promising, but does all this justify the rich valuation?


To the great joy (and relief) of the stock market, Fevertree Drinks (AIM:FEVR), creator of superlative premium mixers, reported in-line results and re-iterated its full year guidance, sending its shares sharply higher.

As well as extending its position as the number one premium mixer brand globally, Fevertree has also started to develop several key adjacent opportunities for the brand, an important aspect to help justify its sky-high valuation.

Group revenue for the…

Continue reading our content…

Gain access to all our excellent content for just £90 per year, that’s just 25p per day for financial freedom.
  • Unlimited access to our market-beating portfolios
  • In-depth coverage of many of the world’s great companies
  • Unique insights from our top research team
Register FREE for access to limited content.
  • Company and markets insights
  • Sponsored content
  • Podcasts

Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Fevertree Drinks

An unusual AIM company with a whopping dividend

10/06/2024 · Company Insights

An AIM company covered here has a lot to say but is certainly flying under the…


Episode 21 of the Investor’s Champion Podcast

08/06/2024 · Podcasts

In this episode of the Investors Champion podcast, hosts Chris and Lee discuss the challenges faced…


More Company Insights

Plenty of growth/plenty of value

Bonkers Bargains: poised to recover

23/07/2024 · James Cropper

Sign-up to our free email updates

SIGN UP